Skip to Content

Guggenheim RBP® Large-Cap Value A TVVAX Fund Analysis

| Medalist Rating as of | See Guggenheim Investment Hub

Morningstar’s Analysis TVVAX

Will TVVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Manager Research

Morningstar Manager Research


The combination of an Average People Pillar rating and a Low Process Pillar rating limit Guggenheim RBP® Large-Cap Value A to a Morningstar Medalist Rating of Negative. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor